This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Heping Lin: Innovator in Arginase Inhibition
Introduction
Heping Lin is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for arginase 1 activity. His work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Heping Lin holds a patent titled "Arginase 1 Binders for Inhibiting Arginase 1 Activity." This patent represents his innovative approach to targeting arginase 1, which plays a vital role in several physiological processes.
Career Highlights
Lin is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His role at Merck allows him to work on cutting-edge research and development projects that aim to improve patient outcomes.
Collaborations
Heping Lin collaborates with esteemed colleagues such as Esther Kofman and Ghassan Najib Fayad. These partnerships enhance the research efforts and contribute to the success of their projects.
Conclusion
Heping Lin's work in the field of arginase inhibition showcases his dedication to innovation and improving healthcare solutions. His contributions are paving the way for future advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile